GlassScriptPhysician profile
Kerry Sander
NPI 1588947147
$9,450.11
in general payments reported to CMS, 2019-2025
49 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,537 · 2022: $3,553 · 2023: $2,463 · 2024: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,300 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,299.57 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,154.94 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $603.72 | 2021-2024 | Trintellix |
| Lilly USA, LLC | $549.59 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $500.85 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $473.51 | 2021-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Corium, LLC | $465.22 | 2022-2024 | Azstarys |
| Vanda Pharmaceuticals INC. | $450.51 | 2021-2023 | Fanapt, Hetlioz |
| Amgen INC. | $428.22 | 2021-2024 | Repatha, Otezla, Prolia |
| Pfizer INC. | $413.42 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $396.71 | 2022-2023 | Farxiga, Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $236.13 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $232.20 | 2021-2023 | Trulance |
| Kowa Pharmaceuticals America, INC. | $204.95 | 2021-2024 | Livalo, Seglentis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $201.27 | 2022-2023 | Caplyta |
| Merck Sharp & Dohme LLC | $197.38 | 2021-2023 | Belsomra, Steglatro, Verquvo |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Sander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.